Newsroom

Recent News Releases

March 9, 2019 3/9/2019 Vedolizumab (Entyvio^®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira^®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis

February 20, 2019 2/20/2019 Takeda's Sustainability Activities Receive Multiple Accolades by Rigorous ESG Evaluators

February 15, 2019 2/15/2019 Shire's Full Year 2018 Results

February 15, 2019 2/15/2019 Notice Regarding Issue of Hybrid Bonds to replace Senior Short Term Loan (Offering of Subordinated Bonds)

February 11, 2019 2/11/2019 European Commission Approves ADCETRIS^® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

Andy Plump on pushing the boundaries of science within the “new” Takeda R&D community

LEARN MORE

Ramona Sequeira, President of Takeda's U.S. Business Unit, on the many opportunities that lie ahead for the “new” Takeda

LEARN MORE

Embracing diversity and inclusion in an expanding global workplace

LEARN MORE

Celebrating Our New Global Reach

LEARN MORE

Takeda’s Transformation: The Next Chapter

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.